RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b
Articolo
Data di Pubblicazione:
2000
Abstract:
Abstract
RANTES (regulated upon activation, normal T-cell expressed and secreted), a CC chemokine, appears to play a role in the pathogenesis of relapsing-remitting multiple sclerosis (RR-MS), enhancing the inflammatory response within the nervous system. We have demonstrated that RANTES production is increased in RR-MS compared to controls. Interferon-β-1b (IFN-β-1b) treatment reduces RANTES production in sera and peripheral blood adherent mononuclear cell (PBAM) supernatants both in relapse and remission. IFN-β-1b also reduces RANTES expression in PBAM. Our results suggest that RANTES modulation might represent one of the mechanisms of action of IFN-β-1b in RR-MS.
Keywords
Chemokines; RANTES; Multiple sclerosis; Interferon-β; Adherent monocytes; RT-PCR
RANTES (regulated upon activation, normal T-cell expressed and secreted), a CC chemokine, appears to play a role in the pathogenesis of relapsing-remitting multiple sclerosis (RR-MS), enhancing the inflammatory response within the nervous system. We have demonstrated that RANTES production is increased in RR-MS compared to controls. Interferon-β-1b (IFN-β-1b) treatment reduces RANTES production in sera and peripheral blood adherent mononuclear cell (PBAM) supernatants both in relapse and remission. IFN-β-1b also reduces RANTES expression in PBAM. Our results suggest that RANTES modulation might represent one of the mechanisms of action of IFN-β-1b in RR-MS.
Keywords
Chemokines; RANTES; Multiple sclerosis; Interferon-β; Adherent monocytes; RT-PCR
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Iarlori, C; Reale, Marcella; Lugaresi, A; DE LUCA, G; Bonanni, Laura; DI IORIO, Angelo; Feliciani, C; Conti, Pio; Gambi, D.
Link alla scheda completa:
Pubblicato in: